Nuvilex - NVLX

Nuvilex (NVLX)
Coverage: March 1, 2013 - March 1, 2014
Featured: March 1, 2013

Latest Newsletter Editions

spacer
Fri, Oct 17, 2014 @ 07:10 am
Hedge Fund Managers- Drowning At Their High Water Marks It seems like we might have had the capitulation sell off this week, with...
Mon, Jul 21, 2014 @ 06:07 am
Nuvilex (NVLX): Shutting Them Up It's been the only thing worth covering in July-It's been radio silence from Staffing 360 (STAF...
Sun, Jul 13, 2014 @ 08:07 am
Nuvilex (NVXL): A Tradeable Bottom? Well, it's July and we're in the middle of the summer doldrums. Microcap stocks are exceptionally...
Fri, May 30, 2014 @ 09:05 am
Nuvilex (NVLX): Don't Be Fooled By Quiet Trading It's been a rather quiet week on the trading front for Nuvilex (NVLX), but it's anything but quiet on the corporate front. It's...
Thu, May 1, 2014 @ 09:05 am
Nuvilex (NVLX): Proving My Theory Today The last edition I published on Nuvilex (NVLX) back on April 19th suggested we had finally...

Click Here For More Newsletters on NVLX

spacer

Latest Blog Entries

spacer

Quote Data

spacer
Last Trade: 0.1685 Bid: 0.0000
Last Size: 10,000 Ask: 0.0000
Trade Time: 9:49am Bid x Ask Size: N/A
Change: down arrow -0.0014 (-0.82%) Day's Range: 0.17 - 0.17
Prev Close: 0.1699 52wk Range: 0.10 - 0.62
Open: 0.1700 P/E (ttm): N/A
Volume: 132,671 EPS (ttm): -0.038
spacer [Chart]

Business Summary

spacer

Disclosure

spacer
MarketBtye LLC was formerly paid a fee of $10,000 and 1 million newly issued restricted shares of Nuvilex by the company for six months of coverage. The 6 months has expired. On November 1, 2013, MarketByte LLC entered into a consulting agreement with Nuvilex to cover the company for an additional 6 months and received 300,00 newly issued restricted shares. MarketByte LLC currently holds no shares of Nuvilex, and has received $83,155.83 in proceed from sales of NVLX in 2014. At present, MarketByte LLC has no contractual obligation to provide coverage of Nuvilex. Therefore, there are no conflicts of interest.

Recent News Headlines

spacer
Nuvilex's Partner Austrianova Successfully Completes First Live Cell Encapsulation in New Facility
Thu, 18 Dec 2014 14:30:00 GMT
[GlobeNewswire] - SILVER SPRING, Md. -- Nuvilex, Inc. (OTCQB:NVLX), a clinical-stage biotechnology company providing cell and gene therapy solutions for the treatment of diseases, today announced that its partner, Austrianova, ...
10-Q for Nuvilex, Inc.
Thu, 18 Dec 2014 00:07:34 GMT
Nuvilex Provides Shareholder Update on Cancer and Diabetes Programs
Tue, 16 Dec 2014 14:30:00 GMT
[GlobeNewswire] - SILVER SPRING, Md. -- Nuvilex, Inc. (OTCQB:NVLX), a clinical-stage biotechnology company providing cell solutions for the treatment of diseases, today announced a shareholder update on the Company's cancer ...
Nuvilex Provides Shareholder Update on Cancer and Diabetes Programs
Tue, 16 Dec 2014 08:53:31 GMT
[at noodls] - Share SILVER SPRING, MD, December 16, 2014 (GLOBE NEWSWIRE) - Nuvilex, Inc. (OTCQB: NVLX), a clinical-stage biotechnology company providing cell solutions for the treatment of diseases, today announced ...
NUVILEX, INC. Files SEC form 10-Q, Quarterly Report
Mon, 15 Dec 2014 21:51:43 GMT
Nuvilex Provides Update on Significance of Austrianova's cGMP Live-Cell Encapsulation Facility
Wed, 10 Dec 2014 14:30:00 GMT
[GlobeNewswire] - SILVER SPRING, Md. -- Nuvilex, Inc. (OTCQB:NVLX), a clinical-stage biotechnology company providing cell therapy solutions for the treatment of diseases, is pleased to provide an update on the significance ...
Nuvilex Announces Name Change of Subsidiary to Viridis Biotech
Mon, 08 Dec 2014 17:17:29 GMT
[at noodls] - Share SILVER SPRING, MD., Dec. 8, 2014 (GLOBE NEWSWIRE) -- Nuvilex, Inc. (OTCQB: NVLX), a preclinical and clinical-stage biotechnology company providing cell therapy solutions for the treatment of diseases, ...
Nuvilex Announces Name Change of Subsidiary to Viridis Biotech
Mon, 08 Dec 2014 14:30:00 GMT
[GlobeNewswire] - SILVER SPRING, Md. -- Nuvilex, Inc. (OTCQB:NVLX), a preclinical and clinical-stage biotechnology company providing cell therapy solutions for the treatment of diseases, announced today that it has changed ...
Nuvilex Announces the Opening of Austrianova's cGMP Live Cell Encapsulation Facility in Thailand
Thu, 04 Dec 2014 18:28:46 GMT
[at noodls] - Share SILVER SPRING, MD, December 4, 2014 (GLOBE NEWSWIRE) - Nuvilex, Inc. (OTCQB: NVLX), a clinical-stage biotechnology company providing cell therapy solutions for the treatment of diseases, announced ...
Nuvilex Announces the Opening of Austrianova's cGMP Live Cell Encapsulation Facility in Thailand
Thu, 04 Dec 2014 14:30:00 GMT
[GlobeNewswire] - SILVER SPRING, Md. -- Nuvilex, Inc. (OTCQB:NVLX), a clinical-stage biotechnology company providing cell therapy solutions for the treatment of diseases, announced today that Nuvilex executives joined Thailand ...
Nuvilex Obtains Exclusive Worldwide License to Develop Disease Treatments that Combine Cell-in-a-Box® and Cannabinoid-Based Medicine
Mon, 01 Dec 2014 16:20:55 GMT
[at noodls] - Share SILVER SPRING, MD, December 1, 2014 (GLOBE NEWSWIRE) - Nuvilex, Inc. (OTCQB: NVLX), a clinical-stage biotechnology company developing cell therapy solutions for the treatment of diseases, announced ...
NUVILEX, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
Mon, 01 Dec 2014 14:30:48 GMT
Nuvilex Obtains Exclusive Worldwide License to Develop Disease Treatments That Combine Cell-in-a-Box(R) and Cannabinoid-Based Medicine
Mon, 01 Dec 2014 14:30:00 GMT
[GlobeNewswire] - SILVER SPRING, Md. -- Nuvilex, Inc. (OTCQB:NVLX), a clinical-stage biotechnology company developing cell therapy solutions for the treatment of diseases, announced today that it has obtained an exclusive ...
Nuvilex Announces the Formation of a Diabetes Consortium for the Development of Its Treatment for Insulin-Dependent Diabetes
Mon, 24 Nov 2014 13:30:00 GMT
[GlobeNewswire] - SILVER SPRING, Md. -- Nuvilex, Inc. (OTCQB:NVLX), a clinical-stage biotechnology company providing cell therapy solutions for the treatment of diseases, announced today that it has formed a "Diabetes ...
Nuvilex Executives in Southeast Asia To Further Advance Cell-in-a-Box Technology®
Fri, 21 Nov 2014 16:02:58 GMT
[at noodls] - Share SILVER SPRING, MD, November 21, 2014 (GLOBE NEWSWIRE) - Nuvilex, Inc. (OTCQB: NVLX), a clinical-stage biotechnology company providing cell therapy solutions for the treatment of diseases, announced ...
Nuvilex Executives in Southeast Asia to Further Advance Cell-in-a-Box Technology(R)
Fri, 21 Nov 2014 14:36:27 GMT
[GlobeNewswire] - SILVER SPRING, Md. -- Nuvilex, Inc. (OTCQB:NVLX), a clinical-stage biotechnology company providing cell therapy solutions for the treatment of diseases, announced today Nuvilex's Chief Executive Officer, ...
Nuvilex Announces Preliminary Data From Preclinical Study of Effects of Its Pancreatic Cancer Treatment on Ascites Fluid Formation
Wed, 19 Nov 2014 14:30:00 GMT
[GlobeNewswire] - SILVER SPRING, Md. -- Nuvilex, Inc. (OTCQB:NVLX), a clinical-stage biotechnology company providing cell therapy solutions for the treatment of diseases, announced today that promising preliminary data ...
Nuvilex Applies in Australia for the Orphan Drug Designation for Pancreatic Cancer Treatment
Fri, 07 Nov 2014 14:30:00 GMT
[GlobeNewswire] - SILVER SPRING, Md. -- Nuvilex, Inc. (OTCQB:NVLX), a clinical-stage biotechnology company providing cell and gene therapy solutions for the treatment of diseases, announced today that it has submitted, ...
Breakthrough Diabetes Research to Be Commercialized by US-Based Nuvilex, Inc.
Mon, 03 Nov 2014 15:49:42 GMT
[Marketwired] - Australian research that has produced a line of insulin producing cells that could eliminate the need for injections for Type 1 diabetics will be commercialized by US company Nuvilex, Inc. and its subsidiaries ...
License For Insuline-Producing Cells Brings Nuvilex, Inc. Closer To “Bio-Artificial Pancreas” To Treat Type 1 Diabetes
Fri, 31 Oct 2014 09:43:07 GMT
[at noodls] - Share Nuvilex, Inc. plans to develop a diabetes treatment using its Cell-in-a-Box® platform technology. In 2013, the company acquired the exclusive worldwide rights to the cellulose-based-live-cell encapsulation ...